Should We Use Standard Survival Models or the Illness-Death Model for Interval-Censored Data to Investigate Risk Factors of Chronic Kidney Disease Progression?

• Julie Boucquemont,

  Affiliation University of Bordeaux, ISPED, Centre INSERM U897 Epidemiology and Biostatistics, Bordeaux, France

  ⨯
• Marie Metzger,

  Affiliations Inserm Unit 1018, CESP, Research Centre in Epidemiology and Population Health, Villejuif, France, University Paris-Sud 11, UMRS 1018, Villejuif, France

  ⨯
• Christian Combe,

  Affiliations Centre Hospitalier Universitaire de Bordeaux, Service de Néphrologie Transplantation Dialyse, Bordeaux, France, Unité INSERM 1026, Univ. Bordeaux, Bordeaux, France

  ⨯
• Bénédicte Stengel,

  Affiliations Inserm Unit 1018, CESP, Research Centre in Epidemiology and Population Health, Villejuif, France, University Paris-Sud 11, UMRS 1018, Villejuif, France

  ⨯
• Karen Leffondre ,

  * E-mail: karen.leffondre@isped.u-bordeaux2.fr

  Affiliation University of Bordeaux, ISPED, Centre INSERM U897 Epidemiology and Biostatistics, Bordeaux, France

  ⨯
• on behalf of the NephroTest Study Group

  ¶The complete membership of the NephroTest Study Group is provided in the Acknowledgments

  ⨯